Month: September 2020

Flemington, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) —Flemington NJ., Global Fiber Technologies, Inc (OTC PINK: GFTX) expects its Authentic Heroes subsidiary to turn in a solid performance in fourth quarter 2020.Chris Giordano, Authentic’ s Chairman and President stated, “All of the cost cutting and consolidation we did starting with the delivery of our equipment to our collaboration partner “Fiber Conversion ‘s” facilities in Broadalbin, NY and shifting our overhead for warehouse and corporate offices to one central location yielded tremendous benefits for us. Our selling, general and administrative expenses are now negligible and we will start reaping the benefits of that strategic move well into the future.We expect to start Fourth Quarter 2020 with three active licenses and end it  with 4 to 5. Most importantly, every license that...

– IBIO-201 Produced Anti-Spike Neutralizing Antibodies in Pre-Clinical Studies –– iBio Plans to Continue Development of IBIO-200, its Virus-Like Particle Platform –NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it has selected IBIO-201, its LicKM™-ubunit vaccine, as its leading candidate for the prevention of SARS-CoV-2 infection.iBio previously announced that preclinical immunization studies with IBIO-200 and IBIO-201, combined with select adjuvants from the Infectious Disease Research Institute (“IDRI”), induced anti-SARS-CoV-2 antibodies. Additional data from cell-based pseudovirus neutralization assay testing demonstrate that IBIO-201 induced the production of more anti-spike neutralizing...

WEST LAFAYETTE, Ind., Sept. 09, 2020 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that it will participate in the H.C. Wainright 22nd Annual Global Investment Conference. The Company will present on Wednesday, September 16th, at 2:30 p.m. EDT.A live webcast of the presentation will be available through a link that will be posted on the Investors section of the Company’s website at ir.inotivco.com and will be available for approximately 90 days.About Bioanalytical Systems, Inc., operating as InotivBASi, operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies...

EAST RUTHERFORD, N.J, Sept. 09, 2020 (GLOBE NEWSWIRE) — MamaMancini’s Holdings, Inc. (OTCQB: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, will release financial results for the second quarter ended July 31, 2020, after market close on Monday, September 14, 2020.Management will host an investor conference call at 8:30 a.m. Eastern time on Tuesday, September 15, 2020 to discuss the Company’s second quarter 2021 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information:Q2 2021 Earnings Conference CallDate: Tuesday, September 15, 2020Time: 8:30 a.m. Eastern timeU.S. Dial-in: 1-844-889-4326International Dial-in: 1-412-317-9264Conference ID: 10147782A playback of the call will be available through September...

WOBURN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held on September 14-16, 2020 virtually.Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will provide an overview of the Company’s business during the live presentation on Monday, September 14, 2020 at 11:00 am Eastern Time and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link: www.hcwevents.com to register for the conference. Once your registration...

PASADENA, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — General Finance Corporation (NASDAQ: GFN), a leading specialty rental services company offering portable storage, modular space and liquid containment solutions in North America and in the Asia-Pacific region of Australia and New Zealand (the “Company”), today announced its consolidated financial results for the fourth quarter and fiscal year ended June 30, 2020.Fourth Quarter 2020 Highlights Leasing revenues in our core non-liquid containment products increased by 6% in North America and 4% in local currency in the Asia-Pacific.Total leasing revenues were $50.4 million, compared to $59.1 million for the fourth quarter of fiscal year 2019.Leasing revenues comprised 60% of total non-manufacturing revenues, compared to 63% for the fourth quarter of fiscal year 2019. Total revenues...

Toronto, Sept. 09, 2020 (GLOBE NEWSWIRE) — Specialist insurer Beazley has enhanced its flagship Beazley Breach Response (BBR) and media & technology (MediaTech) policies for businesses in Canada.As part of Beazley’s ongoing commitment to providing easy to understand policies, the insurer has streamlined these key policy wordings to ensure clarity for brokers and customers in Canada. Cyber extortion, business interruption (BI), dependent business interruption and eCrime coverages have now been integrated into the main policy, rather than being added by endorsement.The BBR policy provides a complete privacy breach response management and information security insurance solution for small to medium-sized businesses. It includes breach response services in addition to first-party coverage for BI, dependent BI, cyber extortion, and...

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — Independence Gold Corp. (TSX.V: IGO) (the “Company”) is pleased to announce the commencement of a diamond drilling program at its 100% owned 3Ts Project, located approximately 185 kilometres (“km”) southwest of Prince George, British Columbia and situated 20 km southwest of Artemis Gold Inc.’s Blackwater Project.The initial program will consist of 11 drill holes totaling approximately 2,200 metres (“m”). The targets are largely based on the extensive compilation and 3D geological model of the epithermal vein system, in addition to the magnetic and spectral surveys, completed in 2019. The 3D model in particular highlighted significant gaps in the historical drilling in the Tommy and Ted-Mint vein systems that the majority of the planned drillholes will be...

FLORHAM PARK, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference at 3:30 p.m. ET on Tuesday, September 15, 2020.Company management will also participate in one-on-one meetings during the virtual conference which runs from September 14-18, 2020.To access the live webcast and archived recordings for each presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations.  Recordings will be available for 60 days following the event.About...

WILMETTE, Ill., BELOIT, Wis. and TYLER, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing urokinase plasminogen activator receptor targeted radio-immuno-therapeutics (uPRITs) for the potential treatment of patients with severe COVID-19, today announced a collaboration with The University of Texas Health Science Center at Tyler (UTHSCT) and its Texas Lung Injury Institute (TLII). UTHSCT is planning to perform in vitro and in vivo studies through the TLII and participate in the clinical development of uPRITs for the treatment of severe COVID-19 through its medical center.The University of Texas Health Science Center at Tyler has taken a leading role in the fight against COVID-19. UTHSCT was recently awarded a $2 million National...